Home › Hypertrophic Cardiomyopathy › Ohio
Hypertrophic Cardiomyopathy clinical trials in Ohio
4 studies for Hypertrophic Cardiomyopathy are looking for participants at sites in Ohio.
Cities in Ohio
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Christ Hospital Health Network, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT05489705Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- Cleveland Clinic, Cleveland
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Jun 4, 2026 · NCT06034405Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
- Cleveland Clinic, Cleveland
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Mar 19, 2026 · NCT05836259HCMR Re-Imaging Study
- Cleveland Clinic, Cleveland
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated Mar 18, 2026 · NCT07054073From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.